Oxidative Stress in a Model of Toxic Demyelination in Rat Brain: The Effect of Piracetam and Vinpocetine

被引:28
作者
Abdel-Salam, Omar M. E. [1 ,2 ]
Khadrawy, Yasser A. [3 ]
Salem, Neveen A. [1 ]
Sleem, Amany A. [2 ]
机构
[1] Natl Res Ctr, Dept Toxicol & Narcot, Cairo, Egypt
[2] Natl Res Ctr, Dept Pharmacol, Cairo, Egypt
[3] Natl Res Ctr, Dept Physiol, Cairo, Egypt
关键词
Toxic demyelination; Ethidium bromide; Vinpocetine; Piracetam; Rat brain; TOTAL ANTIOXIDANT CAPACITY; POSITRON-EMISSION-TOMOGRAPHY; NITRIC-OXIDE LEVELS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; ACETYLCHOLINESTERASE ACTIVITY; AMYLOID PEPTIDE; NOOTROPIC DRUGS; IN-VITRO; BETA;
D O I
10.1007/s11064-011-0450-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We studied the role of oxidative stress and the effect of vinpocetine (1.5, 3 or 6 mg/kg) and piracetam (150 or 300 mg/kg) in acute demyelination of the rat brain following intracerebral injection of ethidium bromide (10 mu l of 0.1%). Results: ethidium bromide caused (1) increased malondialdehyde (MDA) in cortex, hippocampus and striatum; (2) decreased total antioxidant capacity (TAC) in cortex, hippocampus and striatum; (3) decreased reduced glutathione (GSH) in cortex and hippocampus (4); increased serum nitric oxide and (5) increased striatal (but not cortical or hippocampal) acetylcholinesterase (AChE) activity. MDA decreased in striatum and cortex by the lower doses of vinpocetine or piracetam but increased in cortex and hippocampus and in cortex, hypothalamus and striatum by the higher dose of vinpocetine or piracetam, respectively along with decreased TAC. GSH increased by the higher dose of piracetam and by vinpocetine which also decreased serum nitric oxide. Vinpocetine and piracetam displayed variable effects on regional AChE activity.
引用
收藏
页码:1062 / 1072
页数:11
相关论文
共 67 条
[1]   Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis [J].
Alimonti, Alessandro ;
Ristori, Giovanni ;
Giubilei, Franco ;
Stazi, Maria Antonia ;
Pino, Anna ;
Visconti, Andrea ;
Brescianini, Sonia ;
Monti, Micaela Sepe ;
Forte, Giovanni ;
Stanzione, Paolo ;
Bocca, Beatrice ;
Bomboi, Giuseppe ;
D'Ippolito, Cristina ;
Annibali, Viviana ;
Salvetti, Marco ;
Sancesario, Giuseppe .
NEUROTOXICOLOGY, 2007, 28 (03) :450-456
[2]  
[Anonymous], CLIN BIOCHEM
[3]   Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? [J].
Barzilai, A ;
Melamed, E ;
Shirvan, A .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2001, 21 (03) :215-235
[4]   Oxidatively modified proteins in aging and disease [J].
Beal, MF .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (09) :797-803
[5]   Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis [J].
Besler, HT ;
Çomoglu, S .
NUTRITIONAL NEUROSCIENCE, 2003, 6 (03) :189-196
[6]   Multiple cascade effects of oxidative stress on astroglia [J].
Bond, Cherie E. ;
Greenfield, Susan A. .
GLIA, 2007, 55 (13) :1348-1361
[7]   Nitric oxide and neuronal death [J].
Brown, Guy C. .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2010, 23 (03) :153-165
[8]  
Budygin E. A., 1996, Eksperimental'naya i Klinicheskaya Farmakologiya, V59, P6
[9]   The interplay of glutathione-related processes in antioxidant defense [J].
Cnubben, NHP ;
Rietjens, IMCM ;
Wortelboer, H ;
van Zanden, J ;
van Bladeren, PJ .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2001, 10 (04) :141-152
[10]   Does high antioxidant capacity indicate low oxidative stress? [J].
Costantini, David ;
Verhulst, Simon .
FUNCTIONAL ECOLOGY, 2009, 23 (03) :506-509